4.7 Review

Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

Related references

Note: Only part of the references are listed.
Article Oncology

Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years

Dario Callegaro et al.

Summary: The long-term survival of patients who underwent resection for primary RPS has improved over the past 15 years, attributed to better patient selection for resection, quality of surgery, and perioperative patient management, as indicated by the study data.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors

Saveria Tropea et al.

Summary: Surgical factors like extent of surgery, margin status, and histological grade of recurrent tumor, as well as well-differentiated liposarcoma histological subtype, were identified as independent prognostic factors for overall survival and disease specific survival in patients with recurrent retroperitoneal sarcoma. The achievement of clear resection margins was highlighted as a key factor for improving survival outcomes.
Article Oncology

Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)

Carolyn Nessim et al.

Summary: This study evaluated perioperative morbidity after surgery for first locally recurrent retroperitoneal sarcoma, showing that a surgical approach to recurrent RPS is relatively safe and resection of recurrent RPS is a reasonable option. Efforts should be made to minimize the need for blood transfusions.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi - institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

William W. Tseng et al.

Summary: In high-risk RPS patients, the response to neoadjuvant systemic therapy is generally fair. Disease progression during therapy may be a predictor of survival post-surgery. Subtype-specific regimens should be further validated.

CANCER (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on 18F-FDG PET/CT in Patients with Retroperitoneal Liposarcoma

Cheng-Peng Li et al.

Summary: The study evaluated the usefulness of SUVmax on F-18-FDG PET/CT in differentiating subtypes and tumor grades of RPLS. Results showed high sensitivity and specificity of F-18-FDG PET/CT in identifying subtypes and FNCLCC grades of RPLS, with potential as a complementary imaging modality for guiding suitable biopsy location.

CONTRAST MEDIA & MOLECULAR IMAGING (2021)

Article Oncology

The role of 18F-FDG PET/CT in retroperitoneal sarcomas-A multicenter retrospective study

Suren Subramaniam et al.

Summary: This study evaluated the correlation between SUVmax in F-18-FDG PET/CT and the pathologic tumor grade of primary retroperitoneal dedifferentiated liposarcoma and leiomyosarcoma, finding that higher SUVmax was associated with higher histological grade and worse survival outcomes in terms of relapse-free survival and overall survival.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Oncology

Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms

Dario Callegaro et al.

Summary: This study aimed to develop and validate dynamic nomograms for predicting overall survival (OS) and disease-free survival (DFS) in patients with primary retroperitoneal sarcoma (RPS) after surgery. The nomograms showed good calibration and discrimination performance in predicting the 5-year survival probabilities at different time points during the first 5 years of follow-up in RPS survivors.

EUROPEAN JOURNAL OF CANCER (2021)

Article Oncology

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group

Carol J. Swallow et al.

Summary: Primary retroperitoneal sarcomas are rare and complex malignancies that are best managed by experienced multidisciplinary teams in specialized referral centers. Individualized management plans based on consensus statements should be made, and participation in prospective trials and studies is encouraged to improve outcomes.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)

Carolyn Nessim et al.

Summary: The differentiation change in retroperitoneal liposarcoma (RLPS) from primary tumor to first local recurrence appears to impact survival rates, with patients in the DD -> WD and WD -> DD groups showing better overall survival probabilities.

ANNALS OF SURGICAL ONCOLOGY (2021)

Review Oncology

Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program

Dario Callegaro et al.

Summary: The TARPSWG has been successful in producing retrospective studies, playing a pivotal role in clinical trials, and creating consensus papers for the management of retroperitoneal sarcoma. This collaborative effort has significantly advanced the field of research and care for RPS patients.

CURRENT OPINION IN ONCOLOGY (2021)

Article Oncology

Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma

Mrinal Gounder et al.

Summary: The study compared the health-related quality of life between patients with advanced unresectable dedifferentiated liposarcoma treated with selinexor versus placebo. Patients treated with selinexor reported lower pain rates and slower deterioration compared to those who received placebo, while other domains did not show significant differences between the two treatment arms.

FUTURE ONCOLOGY (2021)

Letter Oncology

Disease Biology is King in Retroperitoneal Liposarcoma

William W. Tseng et al.

ANNALS OF SURGICAL ONCOLOGY (2021)

Review Oncology

Definitive Radiotherapy in the Management of Non-Resectable or Residual Retroperitoneal Sarcomas: Institutional Cohort Analysis and Systematic Review

Aleksandra Sobiborowicz et al.

Summary: The study retrospectively analyzed 14 patients with primary or recurrent non-resectable/residual retroperitoneal sarcomas (RPS) and conducted a systematic review. Results showed that radiotherapy achieved satisfactory local disease control in these patients without significant toxicity.

CANCER CONTROL (2021)

Article Oncology

Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database

Christopher C. Stahl et al.

Summary: Nephrectomy during en bloc resection of retroperitoneal sarcoma is associated with an increased risk of postoperative AKI and ARF, despite controlling for age and preoperative renal function. However, nephrectomy did not result in the need for dialysis postoperatively.

ANNALS OF SURGICAL ONCOLOGY (2021)

Review Oncology

Extracellular vesicle cross-talk in the liposarcoma microenvironment

Lucia Casadei et al.

CANCER LETTERS (2020)

Review Oncology

Did outcomes improve in retroperitoneal sarcoma surgery?

Ferdinando Carlo Maria Cananzi et al.

SURGICAL ONCOLOGY-OXFORD (2019)

Review Oncology

Personalizing surgical margins in retroperitoneal sarcomas: an update

Brittany Dingley et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2019)

Review Oncology

Multiply recurrent retroperitoneal liposarcoma

Sanjay P. Bagaria et al.

JOURNAL OF SURGICAL ONCOLOGY (2018)

Article Oncology

Effect of nephrectomy for retroperitoneal sarcoma on post-operative renal function

Daniel B. Kim et al.

JOURNAL OF SURGICAL ONCOLOGY (2018)

Editorial Material Oncology

Strategic Delay: Histology- and Biology-Driven Decision-Making in Recurrent Retroperitoneal Sarcoma

Carol J. Swallow

ANNALS OF SURGICAL ONCOLOGY (2018)

Article Oncology

Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery

Naruhiko Ikoma et al.

JOURNAL OF SURGICAL ONCOLOGY (2017)

Editorial Material Oncology

Surgery for recurrence in retroperitoneal leiomyosarcoma: Is it all about selection?

William W. Tseng et al.

JOURNAL OF SURGICAL ONCOLOGY (2017)

Review Oncology

Treatment of retroperitoneal sarcoma: current standards and new developments

Winan J. van Houdt et al.

CURRENT OPINION IN ONCOLOGY (2017)

Letter Oncology

The Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG): Red wine or white?

William W. Tseng et al.

ANNALS OF SURGICAL ONCOLOGY (2016)

Review Oncology

Management of Recurrent Retroperitoneal Sarcoma

David E. Gyorki et al.

JOURNAL OF SURGICAL ONCOLOGY (2014)

Article Surgery

Predictors of Outcomes in Patients with Primary Retroperitoneal Dedifferentiated Liposarcoma Undergoing Surgery

Emily Z. Keung et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)

Review Radiology, Nuclear Medicine & Medical Imaging

Retroperitoneal sarcomas: A review of disease spectrum, radiological features, characterisation and management

Timothy Shiraev et al.

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2013)

Article Surgery

Is there a role for incomplete resection in the management of retroperitoneal liposarcomas?

D Shibata et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2001)

Article Oncology

Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma

HL Gieschen et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)